Saturday, October 3, 2026

Financial Markets

2 articles

Figure Technology's AAA Blockchain Rating Opens a New Era for Global Tokenized Debt Markets

Figure Technology's AAA Blockchain Rating Opens a New Era for Global Tokenized Debt Markets

A US fintech has secured the first-ever AAA credit rating for a blockchain-based securitization product, a milestone that analysts say could accelerate the adoption of tokenized debt instruments across international capital markets. The achievement by Figure Technology Solutions removes a key fiduciary barrier that has long kept institutional investors worldwide on the sidelines of real-world asset tokenization. Industry observers expect the breakthrough to trigger a wave of similar filings from

ViaNews Editorial Team•
First AAA-Rated Blockchain Securitization Marks a Global Turning Point for Institutional DeFi

First AAA-Rated Blockchain Securitization Marks a Global Turning Point for Institutional DeFi

A landmark AAA credit rating on a blockchain-based loan securitization by US lender Figure Technology Solutions signals that global institutional capital — long barred from decentralised finance by the absence of investment-grade ratings — may finally be ready to enter the space. The development carries implications far beyond Wall Street, touching sovereign wealth funds, European insurance regulators, and emerging market fintech ecosystems seeking credible capital market infrastructure.

ViaNews Editorial Team•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com